Chronic pelvic pain (CPP) is characterised as pain perceived in the pelvic area, occurring for at least six months duration, irrespective of both menstruation and intercourse. CPP may affect both genders, however, it primarily occurs in women. Globally, up to 26% of women experience CPP for greater than a one-year duration.1
CPP is usually non-gynaecological2 with no pelvic disease identified in approximately ONE THIRD of individuals.3
Dr. Lily Tomas explores the complexities of fibromyalgia , including chronic inflammation, risk factors, and the role of mitochondria, mast cells, microglia, and the brain.
Dr. Adrian Lopresti explores pain psychology, the impact of CSS and how these biopsychosocial factors that can affect pain must be considered to optimise treatment.
Following on from Part 1 of our Four Perspectives series, Professor Lesley Braun and our four FX Medicine Ambassadors dive deeper into the therapeutic management of chronic pain and inflammation.
Professor Lesley Braun is joined by our four Ambassadors to gain their four modality-specific perspectives on chronic pain and inflammation.
Professor Peter Drummond, Director of the Centre for Research on Chronic Pain, takes us through the connections between sleep, mood, emotions, and pain.
Emma Sutherland speaks with Natarsha Terreiro, endometriosis patient and endo warrior in the first episode of our three-part series on endometriosis.
Dr. Andrew Orr rounds up the final part of our Endometriosis Series as we look at this complex condition from the perspective of an endometriosis clinical specialist.